Carnitrim
94/100
This product looks safe
- Niacin: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
- 100% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
Label Data
1 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
50 mg
(250% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.4× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
10 mg
(500% DV)
📊 7.7× RDA — above typical dose (UL: 100 mg)
📚 113 studies (Tier A: 3, B: 35)
250 mg
📊 Market median: 500.0mg (861 products)
📚 60 studies (Tier A: 4, B: 13)
250 mg
📊 Market median: 500.0mg (861 products)
📚 60 studies (Tier A: 4, B: 13)
250 mg
📊 Market median: 500.0mg (861 products)
📚 60 studies (Tier A: 4, B: 13)
100 mg
📊 Market median: 260.0mg (249 products)
📚 156 studies (Tier A: 4, B: 61)
Other Ingredients
Microcrystalline Cellulose
Phosphatidylcholine
Hydroxypropyl-Beta-Cyclodextrin
Phytosterol
Stearic Acid
Magnesium Stearate
Titanium Dioxide
Silica
FD&C Red #40
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
📋 Directions for Use
Directions As a dietary supplement, take one (1), tablet twice per day. Do not exceed more than two (2) tablets per day.
⚠️ Warnings & Precautions
Keep out of the reach of children. Not for use by individuals under the age of 18 years.
Consult a physician or licensed qualified health care professional before using this product.
🧪 Formulation Notes
Improve athletic performance Increase energy Burn fat
Energy and weight loss agent
Additional Information
Store in a cool, dry place, away from light.
Visit our website for additional information and guidance.
Product Details
UPC / SKU
6 96302 49538 7
DSLD Entry Date
2020-05-22
Product Type
Other Combinations
Form
Tablet or Pill
Brand
Blackstone Labs
DSLD ID
219533
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Rezistaf
LifeLink
100
Coenzymated B-3 25 mg
Source Naturals
100
Vitamin B Complex
Simply Supplements
100
Test X180 Boost
Force Factor
100
8-Hour Alert
MHP Maximum Human Performance
100